Clinical Trials Browser

Phase 4 × OTHER × olaparib × Clear all

NCT06121401 2025-09-17

IOLANTHE

Phase 4 Active not recruiting

Carcinoma, Ovarian Epithelial

NCT05078671 2024-06-12

PROACTIVE

Phase 4 Recruiting

Neoplasms

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms